Abstract Hypophosphataemia is a common electrolyte disorder which can have clinically significant consequences for bone, muscle, neurological and haematological function. Its causes range from transient transcellular shifts in hospitalised patients to chronic renal phosphate‐wasting disorders mediated by fibroblast growth factor 23 (FGF23). A stepwise diagnostic approach enables identification of the underlying aetiology and guides management. While most cases are managed with removal of causative factors and phosphate supplementation, burosumab has revolutionised the treatment of patients with chronic FGF23‐mediated hypophosphataemia. This review provides a practical framework for the evaluation and management of hypophosphataemia in adults, with focussed discussion of iron infusion‐associated hypophosphataemia, X‐linked hypophosphataemia and tumour‐induced osteomalacia.
Kajanan Parameshwaran, Mawson Wang, Kirtan Ganda. Hypophosphataemia in adults: approach to diagnosis and management. // Internal Medicine Journal. – 2026. – DOI: 10.1111/imj.70645. – URL: https://onlinelibrary.wiley.com/doi/10.1111/imj.70645?af=R
Kajanan Parameshwaran, Mawson Wang, & Kirtan Ganda (2026). Hypophosphataemia in adults: approach to diagnosis and management. Internal Medicine Journal. https://doi.org/10.1111/imj.70645
Kajanan Parameshwaran, et al. “Hypophosphataemia in adults: approach to diagnosis and management.” Internal Medicine Journal, 2026. doi:10.1111/imj.70645.
@article{Parameshwaran2026,
title = {Hypophosphataemia in adults: approach to diagnosis and management},
author = {Parameshwaran, Kajanan and Wang, Mawson and Ganda, Kirtan},
journal = {Internal Medicine Journal},
year = {2026},
doi = {10.1111/imj.70645},
url = {https://onlinelibrary.wiley.com/doi/10.1111/imj.70645?af=R}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...